Cargando…
Naturally Occurring Genetic Alterations in Proximal TCR Signaling and Implications for Cancer Immunotherapy
T cell-based immunotherapies including genetically engineered T cells, adoptive transfer of tumor-infiltrating lymphocytes, and immune checkpoint blockade highlight the impressive anti-tumor effects of T cells. These successes have provided new hope to many cancer patients with otherwise poor progno...
Autores principales: | Kent, Andrew, Longino, Natalie V., Christians, Allison, Davila, Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126620/ https://www.ncbi.nlm.nih.gov/pubmed/34012443 http://dx.doi.org/10.3389/fimmu.2021.658611 |
Ejemplares similares
-
Interpreting T-Cell Cross-reactivity through Structure: Implications for TCR-Based Cancer Immunotherapy
por: Antunes, Dinler A., et al.
Publicado: (2017) -
The T Cell Plasma Membrane Lipid Bilayer Stages TCR-proximal Signaling Events
por: Harder, Thomas
Publicado: (2012) -
The Promise of Personalized TCR-Based Cellular Immunotherapy for Cancer Patients
por: Arnaud, Marion, et al.
Publicado: (2021) -
Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons
por: Zhao, Qijie, et al.
Publicado: (2021) -
The Serial Engagement Model 17 Years After: From TCR Triggering to Immunotherapy
por: Valitutti, Salvatore
Publicado: (2012)